Aculys Pharma
Latest round
- Series C
Last raised
- Mar 2025
Total raised
- $114M
Investors
- 12
About Aculys Pharma
Based in Japan, Aculys Pharma, Inc.Aculys Pharma, Inc. is a pharmaceutical company dedicated to developing innovative treatments for neurological and psychiatric disorders.Aculys Pharma, Inc. specializes in developing pharmaceutical products to meet unmet medical needs in neurology and psychiatry. The company is focused on innovative therapies targeting conditions such as drug-resistant epilepsy and obstructive sleep apnea. Currently, they are working on a nasal formulation of diazepam and pitolisant aimed at enhancing the quality of life for patients.Aculys Pharma generates revenue through the commercialization of its pharmaceutical products, leveraging partnerships with healthcare providers and distributors. Their transaction model includes direct-to-consumer sales and collaborations with hospitals and clinics, focusing on the distribution of flagship products like the nasal diazepam and pitolisant formulations. The company is focused on launching new products designed to address specific medical needs, with a strategy to expand its market presence in the Japanese healthcare sector. They aim to increase accessibility to their innovative therapies, which have already gained traction in international markets.
Who invested in Aculys Pharma
12 investors across 3 rounds
See all investors in Aculys Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aculys Pharma
Who invested in Aculys Pharma?
Aculys Pharma has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aculys Pharma raised?
Aculys Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Aculys Pharma last raise money?
Aculys Pharma's most recent round on record is a Series C, in Mar 2025.
What does Aculys Pharma do?
Based in Japan, Aculys Pharma, Inc.
Where is Aculys Pharma headquartered?
Aculys Pharma is headquartered in Tokyo, Japan.
Which VCs invest in companies like Aculys Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Aculys Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Aculys Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.